OTS964 is a highly potent TOPK inhibitor with tumor suppressive activity in lung cancer (Park et al., 2017) and ovarian cancer (Ikeda et al., 2016), and also serves as a template for synthesizing novel TOPK inhibitors (Hu et al., 2019). This evidence concerns the gene PBK and ovarian carcinoma.